Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 7Cohance Lifesciences
02 6Taro Pharmaceutical Industries
03 32care4
04 7Actavis Inc
05 13Ajanta Pharma Limited
06 7Alkem Laboratories
07 7Alvogen
08 6Amneal Pharmaceuticals
09 7Apotex Inc
10 9Assia Chemical Industries Ltd
11 1FrostPharma AB
12 7Hikma Pharmaceuticals
13 7Lannett Company, Inc.
14 6MSN Laboratories
15 7Mallinckrodt Pharmaceuticals
16 1Medartuum AB
17 2ORIFARM GROUP AS
18 7Prinston
19 7RHODES PHARMACEUTICALS LP
20 15SHIRE PLC
21 21Sandoz B2B
22 13Sun Pharmaceutical Industries Limited
23 47Takeda Pharmaceutical
24 6Takeda Pharmaceuticals Australia Pty. Ltd.
25 13Teva Pharmaceutical Industries
26 7Viatris
01 3CAP
02 20CAPSULE
03 103CAPSULE;ORAL
04 6Caps
05 7Capsule
06 6Capsule, hard
07 10HARD CAPSULES
08 35Kapsel, hard
09 1Mixture, solution
10 12TABLET (CHEWABLE)
11 30TABLET, CHEWABLE;ORAL
12 3capsule
13 3Blank
01 13DISCN
02 3Originator
03 120RX
04 32Schedule G (CDSA I)
05 71Blank
01 3Adult lisdexamfetamine
02 11Aduvanz
03 6Balidax
04 6Dexhility
05 18Elvanse
06 120LISDEXAMFETAMINE DIMESYLATE
07 1Lisarol
08 3Oferlanz
09 6SANDOZ LISDEXAMFETAMINE CAPSULES
10 6TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
11 7TEVA-LISDEXAMFETAMINE
12 26VYVANSE
13 3Volidax
14 6Vyvanse
15 1Vyvanse 30
16 1Vyvanse 50
17 1Vyvanse 70
18 7lisdexamfetamine
19 7Blank
01 6Australia
02 32Canada
03 7India
04 42Norway
05 3South Africa
06 10Sweden
07 6Switzerland
08 133USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 70MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
Dosage Form : TABLET (CHEWABLE)
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 2533340
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
Dosage Form : TABLET (CHEWABLE)
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number : 2533359
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
Dosage Form : TABLET (CHEWABLE)
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number : 2533367
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
Dosage Form : TABLET (CHEWABLE)
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 2533375
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
Dosage Form : TABLET (CHEWABLE)
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 2533383
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Brand Name : TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
Dosage Form : TABLET (CHEWABLE)
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number : 2533391
Regulatory Info : Schedule G (CDSA I)
Registration Country : Canada
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2023-08-25
Application Number : 202802
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2023-08-25
Application Number : 202802
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2023-08-25
Application Number : 202802
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2023-08-25
Application Number : 202802
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2023-08-25
Application Number : 202802
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date : 2023-08-25
Application Number : 202802
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 70MG
Packaging :
Approval Date : 2023-08-25
Application Number : 202802
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2023-08-25
Application Number : 202827
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2023-08-25
Application Number : 202827
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2023-08-25
Application Number : 202827
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2007-02-23
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2007-02-23
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 70MG
Packaging :
Approval Date : 2007-02-23
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 2007-12-10
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2007-12-10
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date : 2007-12-10
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VYVANSE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2014-10-30
Application Number : 21977
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?
